Scott, S., Sangkuhl, K., Gardner, E., Stein, C., Hulot, J., Johnson, J., . . . Shuldiner, A. (2011). Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy. Nature Publishing Group.
Chicago Style aipamenaScott, SA, K. Sangkuhl, EE Gardner, CM Stein, J-S Hulot, JA Johnson, DM Roden, TE Klein, and AR Shuldiner. Clinical Pharmacogenetics Implementation Consortium Guidelines For Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy. Nature Publishing Group, 2011.
MLA aipamenaScott, SA, et al. Clinical Pharmacogenetics Implementation Consortium Guidelines For Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy. Nature Publishing Group, 2011.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.